ARCHIVES

Medicare Should Pay Routine Care For Patients in Trials: IOM.

This article is from The Cancer Letter archive.

Vol. 26 No. 01 | January 7, 2000

Download PDF Visit The Full Archive

Related Articles

Study: Angiopoietin-2 Levels May Predict Lenvatinib Response

October 31, 2014

CCOPs Get $1 Million More, Payline Raised To 228 Plus Exceptions

May 29, 1987

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

New Treatment Approaches For A Variety Of Leukemias Described At ASH Meeting

January 30, 2004

NCI Selects 15 Awardees to Operate the Cancer Information Service.

January 7, 2005

In Brief: Vietti Heads Chairman’s Committee; Chabner Seeks Deputy Candidates; WHO Centers At MSK

December 2, 1988